Ken Griffin Asensus Surgical, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$0.23 - $0.35 $13,984 - $21,280	-60,800 Reduced 93.25%	4,400 $1,000
Q4 2023 Feb 14, 2024	SELL	$0.21 - $0.36 $3,969 - $6,804	-18,900 Reduced 22.47%	65,200 $20,000
Q3 2023 Nov 14, 2023	SELL	$0.26 - $0.61 $1,586 - $3,721	-6,100 Reduced 6.76%	84,100 $22,000
Q2 2023 Aug 14, 2023	BUY	$0.46 - $0.81 $7,590 - $13,365	16,500 Added 22.39%	90,200 $45,000
Q1 2023 May 15, 2023	SELL	$0.36 - $1.0 $23,796 - $66,100	-66,100 Reduced 47.28%	73,700 $48,000
Q4 2022 Feb 14, 2023	BUY	$0.29 - $0.47 $6,380 - $10,340	22,000 Added 18.68%	139,800 $48,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.73 $5,168 - $9,928	13,600 Added 13.05%	117,800 $53,000

40.1M

12.4K

Ticker ASXC
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 236,719,008
Market Cap $82.9M
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.